NBP
NovaBridge BiosciencesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$271.77M
P/E Ratio
—
EPS
$-0.48
Beta
1.74
52W High
$6.79
52W Low
$0.83
50-Day MA
$2.80
200-Day MA
$3.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.68
PEG Ratio
—
About NovaBridge Biosciences
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is headquartered in Rockville, Maryland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-94.20M |
| Operating Margin | 0.00% |
| Return on Equity | -40.90% |
| Return on Assets | -24.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.00 |
| Price-to-Book | 1.18 |
| Price-to-Sales (TTM) | 25.39 |
| EV/Revenue | - |
| EV/EBITDA | 0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $115.65M |
| Float | $148.78M |
| % Insiders | 21.33% |
| % Institutions | 42.13% |
Historical Volatility
HV 10-Day
32.21%
HV 20-Day
37.32%
HV 30-Day
62.44%
HV 60-Day
70.43%
HV Rank
6.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.00 target)
4
BuyData last updated: 4/30/2026